Prenatal Population Screening for Fragile X Carrier and the Prevalence of Premutation Carriers in, Korea |
Han, Sung-Hee
(Division of Molecular Genetics, Department of Laboratory Medicine, Seoul Medical Science Institute, Seoul Clinical Laboratories)
Heo, Yun-Ah (Division of Molecular Genetics, Department of Laboratory Medicine, Seoul Medical Science Institute, Seoul Clinical Laboratories) Yang, Young-Ho (Division of Molecular Genetics, Department of Laboratory Medicine, Seoul Medical Science Institute, Seoul Clinical Laboratories) Kim, Young-Jin (Division of Molecular Genetics, Department of Laboratory Medicine, Seoul Medical Science Institute, Seoul Clinical Laboratories) Cho, Han-Ik (Division of Molecular Genetics, Department of Laboratory Medicine, Seoul Medical Science Institute, Seoul Clinical Laboratories) Lee, Kyoung-Ryul (Division of Molecular Genetics, Department of Laboratory Medicine, Seoul Medical Science Institute, Seoul Clinical Laboratories) |
1 | Pesso R, Berkenstadt M, Cuckle H, Gak E, Peleg L, Frydman M, et al. Screening for fragile X syndrome in women of reproductive age. Prenat Diagn 2000;20:611-4. DOI ScienceOn |
2 | Toledano-Alhadef H, Basel-Vanagaite L, Magal N, Davidov B, Ehrlich S, Drasinover V, et al. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am J Hum Genet 2001;69:351-60. DOI ScienceOn |
3 | Berkenstadt M, Ries-Levavi L, Cuckle H, Peleg L, Barkai G. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests. Prenat Diagn 2007;27:991-4. DOI ScienceOn |
4 | Spence WC, Black SH, Fallon L, Maddalena A, Cummings E, Menapace- Drew G, et al. Molecular fragile X screening in normal populations. Am J Med Genet 1996;64:181-3. DOI ScienceOn |
5 | Cronister A, DiMaio M, Mahoney MJ, Donnenfeld AE, Hallam S. Fragile Xsyndrome carrier screening in the prenatal genetic counseling setting. Genet Med 2005;7:246-50. DOI ScienceOn |
6 | Ryynänen M, Heinonen S, Makkonen M, Kajanoja E, Mannermaa A, Pertti K. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. Eur J Hum Genet 1999;7:212-6. DOI ScienceOn |
7 | Kallinen J, Marin K, Heinonen S, Mannermaa A, Palotie A & Ryynänen M Wide scope prenatal diagnosis at Kuopio University Hospital 1997- 1998: integration of gene tests and fetal karyotyping. Br J Obstet Gynaecol 2001;108: 505-9. |
8 | Hill MK, Archibald AD, Cohen J, Metcalfe SA. A systematic review of population screening for fragile X syndrome. Genet Med 2010;12:396-410. DOI ScienceOn |
9 | Otsuka S, Sakamoto Y, Siomi H, Itakura M, Yamamoto K, Matumoto H, et al. Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain Dev 2010;32:110-4. DOI ScienceOn |
10 | Huang KF, Chen WY, Tsai YC, Lin CC, Chen SH, Tseng CY, et al. Original article pilot screening for fragile X carrier in pregnant women of southern. Taiwan J Chin Med Assoc 2003;66:204-9. |
11 | Song KH, Kim GJ, Whang YJ, Choi SR, Lee SP, Whang BC, et al. Allele distribution of FMR1 gene in Korean women. Kor J Obstet Gynecol 2002;45:990-3. |
12 | Hill MK, Archibald AD, Cohen J, Metcalfe SA. A systematic review of population screening for fragile X syndrome. Genet Med 2010;12:396-410. DOI ScienceOn |
13 | Peprah E. Fragile X syndrome: the FMR1 CGG repeat distribution among world populations. Ann Hum Genet 2012;76:178-91. DOI ScienceOn |
14 | Haddad LA, Mingroni-Netto RC, Vianna-Morgante AM, Pena SD. A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males. Hum Genet 1996;97:808-12. DOI ScienceOn |
15 | Brown WT, Nolin S, Houck G Jr, Ding X, Glicksman A, Li SY, et al. Prenatal diagnosis and carrier screening for fragile X by PCR. Am J Med Genet 1996;64:191-5. DOI ScienceOn |
16 | Chen L, Hadd A, Sah S, Filipovic-Sadic S, Krosting J, Sekinger E, et al. An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis. J Mol Diagn 2010;12:589-600. DOI ScienceOn |
17 | Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, Zhang W, et al. A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 2010;56:399-408. |
18 | Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Warren Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-14. DOI ScienceOn |
19 | Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol 2007;6:45-55. DOI ScienceOn |
20 | Musci TJ, Moyer K. Prenatal carrier testing for fragile X: counseling issues and challenges. Obstet Gynecol Clin North Am 2010;37:61-70. DOI ScienceOn |
21 | Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 2008;10:43-9. DOI ScienceOn |
22 | Maddalena A, Richards CS, McGinniss MJ, Brothman A, Desnick RJ, Grier RE, et al. Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med 2001;3:200-5. DOI ScienceOn |
![]() |